Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.550
+0.080 (5.44%)
At close: Jan 2, 2026, 4:00 PM EST
1.830
+0.280 (18.06%)
Pre-market: Jan 5, 2026, 5:13 AM EST
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $142.41 million as of January 5, 2026. Its market cap has increased by 39.62% in one year.
Market Cap
142.41M
Enterprise Value
65.61M
1-Year Change
39.62%
Ranking
Category
Stock Price
$1.55
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $142.41M, an increase of 179.09%. That is a compound annual growth rate of 27.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2026 | 142.41M | 5.44% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |